Search Results - asal+homayouni

1 Results Sort By:
MicroRNAs As Targets for Anti-Angiogenic Therapies
C05032: MicroRNAs As Targets for Anti-Angiogenic Therapies Technical Details: MicroRNAs (miRNAs) are 18-24 nucleotide RNA molecules that regulate the stability or translational efficiency of target mRNAs. miRNAs are frequently dysregulated in cancer cells and can act as oncogenes and tumor-suppressors. The proto-oncogene c-MYC encodes a transcription...
Published: 6/27/2024   |   Inventor(s): Michael Dews, Asal Homayouni, Erik Wentzel, Andrei Thomas-Tikhonenko, Joshua Mendell
Keywords(s): Biologics, Cancers, Disease Indication, Gene Therapy, Nucleic Acid, Single, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities, Technology Classifications > Research Tools > Nucleic Acids
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum